Adeptus Health Reports Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Jefferies Cuts Price Target on Adeptus Health (ADPT) Following 2Q Report; Reiterates Buy
July 22, 2016 8:54 AM EDTJefferies maintained a Buy rating on Adeptus Health (NYSE: ADPT), and cut the price target to $100.00 (from $113.00), following the company's 2Q earnings report. Q2 results mostly came in below expectations and at the low end of management's guidance. Jefferies does not expect meaningful... More
Adeptus Health (ADPT) Misses Q2 EPS by 3c
July 21, 2016 6:52 AM EDTAdeptus Health (NYSE: ADPT) reported Q2 EPS of $0.48, $0.03 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $100.2 million versus the consensus estimate of $93.92 million.
2016 Guidance Reaffirmed
We continue to expect systemwide net patient services revenue, which includes revenue... More
